The premier life science incubator empowering and enabling innovators to deliver life-enhancing health and wellness solutions to people around the globe.
JLABS in innovation hotspots around the world
Because we know great ideas can come from everywhere. Whenever you feel inspired and are ready to move your breakthrough ideas in healthcare forward to reach patients and consumers, we have a community of state of the art JLABS waiting for you.
"South San Francisco, Calif.-based Boost Biomes’ technology works to increase the productivity of beneficial microbes that impact how plants use water and soil nutrients."
Wall Street Journal
If you’re driven by something that’s very mission-based, very values-based, then you’re willing to buck the system.
Entrepreneur Magazine
“Every week I meet companies on the edge of innovation and health care—new consumer products, pharmaceutical or biotech developments, as well as medical devices. I really do feel like I have the coolest job in San Diego.”
San Diego Magazine
"With the continued acceleration of novel science and health care technologies in areas like artificial intelligence, digital therapeutics and the human microbiome we have tremendous opportunity to search the haystack in new and exciting ways."
Scientific American
"Xconomy: What do you wish your 25-year-old self knew (or was told?)
Melinda Richter: "You are good enough. You’re strong enough. You’re capable enough."
Xconomy
"Bringing the NY entrepreneurs and startups together with the investors is what we're all about."
Life Science Leader
"Silicon Valley isn't the only place to be a successful entrepreneur - you can be a hero in your home town - and that innovation resides as much outside big companies like J&J as it does inside; JLabs looks to catalyse innovation and accelerate it."
The Straits Times
Residents
Check out what some of our resident companies are working on, how they're tackling challenging problems in new and innovative ways.
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator
JLABS @ BE
By: syndesi therapeutics
Syndesi Therapeutics announces initiation of Phase I study of novel SV2A modulator, SDI‐118, in development for the treatment of cognitive impairment.
JLABS @ BE
By: syndesi therapeutics
Syndesi Therapeutics Awarded Non-dilutive Funding of up to €3.2M for Development of its Lead Program, SDI-118, Aimed at Treating Cognitive Impairment
JLABS @ BE
By: Calypso Biotech
Calypso Biotech BV secures 20 Million EUR in Series A Financing to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases
JLABS @ BE
By: Genome Biologics
Genome Biologics wins prestigious Horizon 2020 EU Phase 2 grant award
JLABS @ NYC
By: Mobile Sense Technologies
Johnson & Johnson Opens JLABS @ NYC
JLABS @ TMC
By: Intuitap Medical
Riding the Start-Up Roller Coaster: What It's Really Like to Be a Healthcare Entrepreneur
JLABS @ SSF
By: Ideaya Biosciences
IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.
JLABS @ San Diego
By: Sirenas
Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic t...
JLABS @ Toronto
By: Nanovista Inc.
Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials
JLABS @ MBC BioLabs
By: Symic Biomedical
Symic Bio Completes the MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Knee Osteoarthritis
JLABS @ SSF
By: Imago Biosciences
Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies
